The pre-supplementation cycling trial induced a significant rise of median cardiac troponin T concentrations from 3.2 ( IQR 3.0-4 .2 ) to 4.7 ng/L ( IQR 3.7-6 .7 ) , immediately post-exercise ( p < 0.001 ) .